Accuracy in direction. I started with penny stocks then forex. Through it all I stuck with reading the charts and understanding it. I've used tradeview as a diary for myself.
AEZS
A strong opportunity to buy a company's stock
It may drop more, do not be afraid, it is a second opportunity to buy, I cannot determine the time when the company’s stock will rise, this is only known to the market maker, for this patience is important in trading a company’s stock
I can't explain the strategy, it's secret, I'm honored that you follow me on...
AEterna has a variety of new products in its pipeline.
Macrilen, for example, is the first and only FDA-approved oral test for the diagnosis of Adult Growth Hormone Deficiency.
AEterna received European approval to market Macrillen.
Dr. Christian Strasburger: "Clinical studies have demonstrated that macimorelin is safer and much simpler to administer than the...
The company's stock is in the consolidation stage strongly
The stock is now buy
I do not recommend Stop Loss because you will be taken out by the market makers
I cannot say more details about my strategy as it is very confidential
The 9ema is crossing the 20ema and the current price is at the YTD POC line. The MACD crossed a few days ago . I would like to see it hold $1.03 for a long swing to: $1.45 and $1.87
Based off trend lines.
AEZS recently gained compliance
Volume has been low the last few days compared to average
Earnings to be announced on March 30th
Aeterna Zentaris Inc (NASDAQ: AEZS) has exercised its option announced on February 2, and entered into an exclusive worldwide sub-licensable patent and know-how license agreement for a potential COVID-19 vaccine.
The vaccine is currently in preclinical development and was invented at the Julius-Maximilians-University in Wuerzburg.
Additionally, the Company has...
AEZS: Aeterna Zentaris Inc
2021-03-15 08:05:00
Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with Julius-Maximilians-University Wuerzburg for Development of a Potential Oral Prophylactic Bacterial Vaccine Against COVID-19
Bullish Indicators
- Falling Wedge
- Wide RSI Divergence
- Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference March 9-10
AEZS .... PULLBACK ...WEDGE SISTEM RETURN AFTER PUBBLIC OFFERT..... STAY TUNED THE SAME MODEL AS CLSN ATOS......TO BE PATIENCE AND FO.LOW THE PREVISION
Bullish Flag
Pros:
Descending volume during formation
Golden cross in blue
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 8
250RSI above 50
Cons:
200MA Flat
PT = 5.09$
Running a morning scan on finviz (need to figure out how to do that here) came up with Aeterna Zentaris. One of those times it feels risky to buy a 10,000 shares at $1 and then at $3 you think, I should have bought more!
Last February this would be worth 1000%. Hard to tell how the market will treat this opportunity one year later. No reasonable charting to do...
